APRE
Aprea Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.49
−8.22%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-32.0%
Return on equity
-29.1%
Return on assets
-34.4%
Return on invested capital
0.00x
Asset turnover
-$12.2M
Cash from operations
$3.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026